Substance active (DCI)
- paclitaxel (dans une formulation de nanoparticules liées à l’albumine)
Informations techniques
Présentation
PAZENIR 5 mg/mL, poudre pour dispersion pour perfusion
1 flacon en verre de 100 mg (CIP : 34009 301 845 9 2)
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
MUAF5LWnxXneHBeJ
Écouter
Français